CTRI/2024/08/071776尚未招募Unknown
To study the efficacy of Cabergoline as an adjunct to Metformin in management of overweight & obese women with PCOS
il0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women diagnosed with PCOS by Rotterdam
- •criteria, Age 16-35 years, BMI 23-35 kg/m2, Willing to participate in the study
排除标准
- •Patients with other endocrine disorders such as
- •Cushing’s Syndrome, acromegaly, pituitary
- •adenoma, etc , Women planning pregnancy in next 6 months, Intolerability to cabergoline, Not willing to participate
研究者
相似试验
Unknown
不适用
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant ProlactinomasResistance, DiseaseProlactinomaNCT03400865Zhebao Wu30
已完成
1 期
A Pilot Study of Cabergoline for the Treatment of Cocaine DependenceCocaine DependenceCocaine AbuseCocaine AddictionSubstance AbuseNCT01651364Baylor College of Medicine11
已完成
3 期
Treatment of uterine myoma.fibromyoma of uterus.Leiomyoma of uterusfibromyoma of uterusIRCT201403092624N12Vice chancellor for research ,Iran University of Medical Sciences.50
已完成
3 期
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSRestless Legs SyndromeNCT00627003Pfizer43
已完成
3 期
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSRestless Legs SyndromeNCT00625547Pfizer361